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Abstract
Purpose:  To  evaluate  reproducibility  and  variations  in  apparent  diffusion  coefﬁcient  (ADC)  mea-
surement  in  normal  pancreatic  parenchyma  at  1.5-  and  3.0-Tesla  and  determine  if  differences
may exist  between  the  four  pancreatic  segments.
Materials  and  methods:  Diffusion-weighted  MR  imaging  of  the  pancreas  was  performed  at  1.5-
Tesla in  20  patients  and  at  3.0-Tesla  in  other  20  patients  strictly  matched  for  gender  and  age
using the  same  b  values  (0,  400  and  800  s/mm2).  Two  independent  observers  placed  regionsReproducibility
assessment
of interest  within  the  four  pancreatic  segments  to  measure  ADC  at  both  ﬁelds.  Intra-  and
inter-observer  agreement  in  ADC  measurement  was  assessed  using  Bland-Altman  analysis  and
comparison  between  ADC  values  obtained  at  both  ﬁelds  using  non-parametrical  tests.
Results:  There  were  no  signiﬁcant  differences  in  ADC  between  repeated  measurements  and
between  ADC  obtained  at  1.5-Tesla  and  those  at  3.0-Tesla.  The  95%  limits  of  intra-observer
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agreement  between  ADC  were  2.3%—22.7%  at  1.5-Tesla  and  1%—24.2%  at  3.0-Tesla  and  those  for
inter-observer  agreement  between  1.9%—14%  at  1.5-Tesla  and  8%—25%  at  3.0-Tesla.  ADC  values
were similar  in  all  pancreatic  segments  at  3.0-T  whereas  the  tail  had  lower  ADC  at  1.5-Tesla.
Conclusion:  ADC  measurement  conveys  high  degrees  of  intra-  and  inter-observer  reproducibility.
ADC have  homogeneous  distribution  among  the  four  pancreatic  segments  at  3.0-Tesla.
© 2012  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
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tDiffusion-weighted  magnetic  resonance  imaging  (DWI)  with
quantitative  measurement  of  apparent  diffusion  coefﬁcient
(ADC)  values  has  a  well-established  role  in  the  detection
and  characterization  of  a  variety  of  abdominal  abnormalities
[1—7].  Regarding  pancreatic  disease,  several  researchers
have  demonstrated  that  DWI  with  ADC  measurement  is
helpful  to  detect  and  further  characterize  focal  pancreatic
lesions  [8—11]  and  diffuse  pancreatic  conditions  [12,13].
However,  before  ADC  measurement  can  be  considered  as
a  robust  and  discriminating  tool,  the  range  of  ADC  values
within  the  normal  pancreas  as  well  as  their  reproducibility
should  be  investigated.  In  addition,  a  potential  limitation
of  DWI  is  that  reproducibility  in  ADC  measurement  may  be
affected  by  the  ﬁeld  strength  [1].
Several  studies  have  investigated  the  reproducibility  of
ADC  measurement  of  many  intra-abdominal  organs  and  they
found  marked  variations  at  both  1.5-  and  3.0-Tesla  (T)
[5,14,15].  By  contrast,  data  reporting  the  reproducibility
of  ADC  measurement  of  the  pancreas  are  scarce.  A  recent
study  found  no  signiﬁcant  differences  in  ADC  values  of
the  pancreas  between  ADC  values  obtained  at  1.5-T  and
those  obtained  at  3.0-T  [16]. However,  this  study  did  not
investigate  the  intra-  and  inter-observer  variability  in  ADC
measurement  at  each  ﬁeld  strength  [16]. Another  study
found  no  signiﬁcant  differences  in  ADC  measurement  of  the
normal  pancreas  at  3.0-T  but  did  not  make  a  comparison
with  results  obtained  at  1.5-T  [15]. Because  of  limited  avail-
able  results  in  the  literature  and  possible  inﬂuence  of  the
ﬁeld  strength  on  the  resulting  ADC  value  and  its  reproducibil-
ity  in  measurement,  a  study  that  addresses  these  concerns
should  be  done.
Accordingly,  we  performed  this  study  with  two  goals  in
mind.  First,  we  tried  to  analyze  intra-  and  inter-observer
variability  in  ADC  measurement  of  the  pancreas  at  1.5-  and
3.0-T.  Second,  we  wished  to  assess  possible  variations  in  ADC
values  among  the  different  pancreatic  segments  in  patients
without  pancreatic  disease.
Materials and methods
Patients
This  retrospective,  single-center  study  was  approved  by
our  institutional  review  board  and  informed  consent  was
waived.  From  January  2011  through  January  2012,  our  MR
imaging  database  was  retrospectively  queried  to  identify  all
cases  of  patients  referred  for  abdominal  MR  imaging  at  3.0-
T.  Patients  were  selected  when  they  had  MR  imaging  of  the
abdomen  at  3.0-T  for  conditions  unrelated  to  the  pancreas,
no  visible  pancreatic  disease  and  no  pancreatic  atrophy  with
c
r
a
uatty  replacement  at  MR  imaging,  and  a  DWI  examination
hat  entirely  covered  the  pancreas.  After  review  of  clinical
les,  patients  with  body  mass  index  greater  than  25  kg/m2,
iabetes,  exocrine  or  endocrine  pancreatic  dysfunction,  cys-
ic  ﬁbrosis,  chronic  hepatic  disease,  hepatic  steatosis,  prior
istory  of  cancer  or  systemic  chemotherapy  were  excluded.
ll  selected  patients  had  normal  results  of  laboratory  blood
ests  including  serum  lipase  and  glucose  levels.
Twenty  patients  (10  males  and  10  females)  with  a  mean
ge  of  47.7  years  ±  14.5  years  (SD)  (range:  19—78  years)  who
nderwent  abdominal  MR  imaging  examination  at  3.0-T
ncluding  pancreatic  study  fulﬁlled  the  inclusion  criteria.
hey  were  further  strictly  matched  for  gender  and  age
o  20  patients  (10  males  and  10  females)  with  a  mean
ge  of  47.7  years  ±  14.5  years  (SD)  (range:  19—78  years)  who
ad  abdominal  MR  imaging  examination  at  1.5-T  during  the
ame  period  and  fulﬁlled  the  same  inclusion  and  exclusion
riteria.
R examination protocol
ll  patients  underwent  MR  imaging  examination  of  the
bdomen  using  a  1.5-T  system  (Magnetom  Avanto,  Siemens
ealthcare,  Erlangen,  Germany,  running  software  Syngo  MR
15)  or  a  3.0-T  system  (Magnetom  Verio,  Siemens  Health-
are,  running  software  Syngo  MR  B13).  High-resolution
ree-breathing  T2-weighted  fast  spin-echo  sequence  with
espiratory  triggering  using  prospective  acquisition  cor-
ection  and  three-dimensional  volumetric  interpolated
reath-hold  gradient-echo  (3D  VIBE)  sequence  before  and
fter  intravenous  administration  of  a  gadolinium-chelate
equence  were  obtained  in  all  patients  in  addition  to  DWI
equence.
All  imaging  examinations  obtained  at  1.5-T  were  per-
ormed  using  one  anterior  torso  phased-array  coil  and  one
osterior  phased-array  coil  with  nine  channels  each.  All
maging  examinations  obtained  at  3.0-T  were  performed
sing  one  anterior  torso  phased-array  coil  and  one  poste-
ior  phased-array  coil  with  16  channels  each.  Patients  were
maged  in  supine  position.
DWI  was  performed  with  a  fat-suppressed  single-shot
pin-echo  echo-planar  diffusion-weighted  technique  in  the
xial  plane  with  10  gradient  factors  (b  values  =  0,  10,  20,
0,  50,  80,  100,  200,  400  and  800  sec/mm2)  within  the
ame  acquisition.  The  diffusion  gradients  were  applied  in
hree  orthogonal  directions  along  the  three  main  axes  of
he  magnet  bore.  The  single-shot  EPI  readout  was  pre-
eded  by  a  diffusion-sensitizing  block  consisting  of  two  180◦
adiofrequency  pulses.  Parallel  imaging  with  generalized
utocalibrating  partially  parallel  acquisition  (GRAPPA)  was
sed  with  an  acceleration  factor  (or  reduction  factor)  of  2.
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ll  DWI  examinations  were  performed  with  fat  suppression
hat  consisted  in  a  spectral-fat  saturation  technique.  DWI
as  obtained  using  a  respiratory-triggered  acquisition  and
rior  to  gadolinium-chelate  administration  in  all  patients.
WI  protocols  used  at  both  ﬁelds  are  described  in  Table  1.
mage analysis
he  ADC  maps  were  obtained  from  the  source  data  using  a
ommercially  available  workstation  (MMWP  with  the  Syngo
oftware,  Siemens  Healthcare).  ADC  values  were  calculated
ith  three  b  values,  including  the  b  =  0,  400  and  800  values
ec/mm2,  using  a  mono-exponential  ﬁtting  algorithm  on  the
asis  of  ln  (SI)  as  a  function  of  b  value,  where  SI  is  the  sig-
al  intensity  of  the  pancreatic  segment.  Because  the  b  =  0
alue  was  included  for  ADC  calculation,  the  resulting  ADC
as  the  ADC  total  and  we  did  not  separate  perfusion  and
rue  diffusion  effects  [16].
Two  independent  observers  (one  fourth-year  resident
n  radiology,  further  referred  to  as  reader  1,  and  one
adiologist  with  21  years  of  experience  in  interpreting
bdominal  MR  images,  further  referred  to  as  reader  2)
laced  regions  of  interest  (ROIs)  on  each  pancreatic  seg-
ent  on  the  diffusion-weighted  images  obtained  with
 =  0  sec/mm2 (Fig.  1).  Special  care  was  given  to  avoid
ancreatic  vessels,  pancreatic  ducts  and  artifacts  in  ROI
lacement.  Circular  ROIs  with  a  minimum  size  of  100  pix-
ls  were  placed  on  each  of  the  four  pancreatic  segments
y  each  observer.  However,  ROI  sizes  varied  according  to
xial  dimensions  of  the  pancreatic  segment  being  analyzed.
he  ROIs  were  transferred  from  the  b0 images  to  the  ADC
aps.  ADCs  were  measured  three  times  by  each  observer
nd  the  three  measurements  were  averaged  for  each
ancreatic  segment  on  DWI  examinations  obtained  at
c
w
c
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Table  1  MR  Imaging  acquisition  parameters  for  two  diffusion-
Field  strength  1.5-Tesla  
MR  unit  Magnetom  Avanto  VB15
Receiver  channels  18  
Gradient  strength  (mT/m)/maximal
gradient  slope  (T/m/sec)
45/200  
EPI  technique  Fat-suppressed  single-s
echo-planar  imaging
Gradient  factors  b  values  =  0,  10,  20,  30,
200,  400  and  800  sec/m
TR  (msec)/TE  (msec)  1300/52  
Echo  spacing  (msec)  0.83  
Receiver  bandwidth  (Hz/pixel)  1.347  
Acquisition  time  (sec)  300  
Number  of  axial  sections  26  
Echo-planar  imaging  factor  104  
Respiratory  triggering  Yes  
Number  of  signal  averages  2  
Field  of  view  (mm)  340  
Voxel  size  (mm3)  2.5  ×  2.5  ×  7  
Matrix  size  104  ×  128  
Section  thickness  (mm)  7  
Intersection  gap  (mm)  0  
TR: repetition time; TE: echo time; EPI: echo-planar imaging; T: Tesla.M.  Barral  et  al.
.5-T.  The  same  approach  was  made  for  ADC  measurements
t  3.0-T.  For  the  evaluation  of  intra-observer  variability,
eader  1  made  ADC  calculations  twice  during  two  different
essions  that  were  separated  by  a 3-week  interval  to  avoid
ny  recall  bias.
The  four  pancreatic  segments  were  deﬁned  as  follows:
he  head  was  deﬁned  as  the  pancreatic  segment  located
etween  the  superior  mesenteric  vein  and  the  gastroduode-
al  artery,  that  lies  to  the  right  of  the  superior  mesenteric
rtery;  the  neck  (or  isthmus)  was  the  thin  section  between
he  head  and  the  body  of  the  gland  that  lies  anterior  to
he  conﬂuence  of  the  superior  mesenteric  vein  and  splenic
ein,  which  groove  its  posterior  aspect;  the  body  was  deﬁned
s  the  longest  portion  of  the  pancreas,  extending  from  the
eck  and  passing  to  the  tail,  lying  to  the  left  of  the  superior
esenteric  vessels;  the  tail  was  deﬁned  as  the  ﬁnal  portion
f  the  left  pancreas,  that  lies  anterior  to  the  left  kidney
djacent  to  the  splenic  hilum  [17].
tatistical analysis
esults  of  ADC  measurements  for  each  pancreatic  segment
ere  expressed  as  medians,  ﬁrst  quartiles  (q1),  third  quar-
iles  (q3)  and  ranges.  Intra-  and  inter-observer  agreement
n  ADC  measurements  at  1.5-  and  3.0-T  was  determined  as
ean  absolute  difference  (bias)  and  95%  conﬁdence  interval
f  the  mean  difference  (limits  of  agreement)  according  to
he  method  of  Bland  and  Altman  [18]  and  expressed  as  per-
entages  of  median  ADC  values.  The  results  of  reader  1  were
sed  for  assessment  of  intra-observer  variability.  Pairwise
omparisons  of  the  ADC  values  obtained  by  the  two  observers
ere  made  using  the  Wilcoxon  signed  rank  test;  for  this
omparison,  the  results  of  the  ﬁrst  ADC  measurements  of
eader  1  were  used.  For  each  pancreatic  segment,  ADC
weighted  sequences  obtained  at  1.5-  and  3.0-Tesla.
3.0-Tesla
 Magnetom  Verio  B13
32
70/200
hot  spin-echo Fat-suppressed  single-shot  spin-echo
echo-planar  imaging
 50,  80,  100,
m2
b  values  =  0,  10,  20,  30,  50,  80,  100,
200,  400  and  800  sec/mm2
2911/66
0.95
1.346
310
30
104
Yes
1
290
2.3  ×  2.3  ×  5.0
104  ×  128
5
0.5
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Figure 1. Diffusion-weighted MR Imaging of the pancreas. A. A circular region of interest (ROI) (arrow) is placed on the pancreatic tail
for o
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o
−
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neck,  6.7%  for  the  body  and  24.2%  for  the  tail.  Graphic
illustration  of  these  data  with  Bland-Altman  plots  is
displayed  in  Fig.  3.
Table  2  Apparent  diffusion  coefﬁcient  (ADC)  values
(×  10−3 mm2/s)  obtained  at  1.5-Tesla  from  the  four  pan-
creatic  segments  during  two  repeated  measurements  by
the  same  reader  (reader  1,  intra-observer  comparison).
First  measurement  Second
measurement
P value
Head  1.239
(1.155;  1.455)
[0.802—1.819]
1.268
(1.125;  1.414)
[0.735—1.844]
0.7510
Neck  1.311
(1.107—1.480)
[0.725—1.660]
1.286
(1.007—1.447)
[0.799—1.575]
0.2043
Body 1.171
(1.064;  1.315)
[0.757—1.617]
1.175
(1.034;  1.353)
[0.734—1.523]
0.6012
Tail 1.018
(0.946;  1.256)
[0.749—1.663]
.993
(0.930;  1.226)
[0.785—1.599]
0.3317
Data are expressed as medians, numbers in parentheses areusing diffusion-weighted trace image obtained with b = 0 sec/mm2
image to the pixel-based apparent diffusion coefﬁcient (ADC) map 
values  obtained  at  1.5-T  were  compared  to  those  obtained
at  3.0-T  using  the  Mann-Whitney  test;  the  results  of  the  ﬁrst
ADC  measurements  of  reader  1  were  used  for  this  compari-
son.  ADC  values  obtained  at  1.5-T  were  compared  between
segments  with  the  Kruskal-Wallis  test  for  overall  comparison
and  the  Wilcoxon  signed  rank  test  was  used  when  overall
comparison  was  signiﬁcant.  The  same  comparison  was  made
with  ADC  values  obtained  at  3.0-T.
R  version  2.8  (R  Foundation,  http://www.r-project.org/)
was  used  for  statistical  analysis.  All  statistical  tests  were
two-tailed  and  statistical  signiﬁcance  was  considered  at
P  <  05.
Results
Intra-observer variability
The  ADC  values  calculated  for  the  four  pancreatic  segments
during  the  two  repeated  measurements  of  reader  1  at  1.5-T
and  at  3.0-T  are  showed  in  Tables  2  and  3.  No  signiﬁcant
differences  in  ADC  measurements  were  found  for  each  of
the  four  pancreatic  segments  being  considered  at  1.5-  and
3.0-T.
At  1.5-T,  the  mean  absolute  difference  (bias)  and
95%  conﬁdence  intervals  of  the  mean  difference  (lim-
its  of  agreement)  for  the  head,  neck,  body  and  tail
were  0.003  ×  10−3 mm2/s  [—0.234  ×  10−3—0.240  ×  10−3],
0.029  ×  10−3 mm2/s  [—0.162  ×  10−3—0.220  ×  10−3],
0.009  ×  10−3 mm2/s  [—0.174  ×  10−3—0.191  ×  10−3]  and
0.012  ×  10−3 mm2/s  [—0.124  ×  10−3—0.149  ×  10−3],  respec-
tively.  The  95%  limits  of  agreement  between  ADC  values
obtained  on  repeated  DWI  examinations  by  the  reader  1
were  2.3%  of  the  mean  ADC  value  for  the  head,  22.7%
for  the  neck,  7.5%  for  the  body  and  11%  for  the  tail.
Graphic  illustration  of  these  data  with  Bland-Altman  plots
is  displayed  in  Fig.  2.
At  3.0-T,  the  mean  absolute  difference  (bias)  and
95%  conﬁdence  intervals  of  the  mean  difference  (limitsptimal placement. B. The ROI (arrow) is transferred from the b0
DC calculation.
f  agreement)  for  the  head,  neck,  body  and  tail  were
0.001  ×  10−3 mm2/s  [−0.139  ×  10−3 −0.137  ×  10−3],
0.014  ×  10−3 mm2/s  [−0.219  ×  10−3—0.192  ×  10−3],
.008  ×  10−3 mm2/s  [−0.143  ×  10−3—0.160  ×  10−3]  and
.028  × 10−3 mm2/s  [−0.148  ×  10−3—0.203  ×  10−3],  respec-
ively.  The  95%  limits  of  agreement  between  ADC  values
btained  on  repeated  DWI  examinations  by  the  reader  1
ere  1%  of  the  mean  ADC  value  for  the  head,  11%  for  theﬁrst quartiles (q1) and third quartiles (q3), numbers in brackets
are ranges. Comparisons were made using the Wilcoxon signed
rank test.
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Figure 2. Intra-observer reproducibility of apparent diffusion coefﬁcient (ADC) measurement (× 10−3 mm2/s) at 1.5-T for the four pancre-
atic segments. Bland-Altman plots of difference of ADC measurements (y-axis) against mean ADC measurement (x-axis), with mean absolute
difference (bias) (continuous line) and 95% conﬁdence interval of the mean difference (limits of agreement) (dashed lines).
Figure 3. Intra-observer reproducibility of apparent diffusion coefﬁcient (ADC) measurement (× 10−3 mm2/s) at 3.0-T for the four pancre-
atic segments. Bland-Altman plots of difference of ADC measurements (y-axis) against mean ADC measurement (x-axis), with mean absolute
difference (bias) (continuous line) and 95% conﬁdence interval of the mean difference (limits of agreement) (dashed lines).
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Table  3  Apparent  diffusion  coefﬁcient  (ADC)  values
(×  10−3 mm2/s)  obtained  at  3.0-Tesla  from  the  four  pan-
creatic  segments  during  repeated  measurements  by  the
same  reader  (reader1,  intra-observer  comparison).
First  measurement  Second
measurement
P value
Head 1.286
(1.154;  1.415)
[0.909—1.883]
1.292
(1.140;  1.464)
[0.842—1.887]
0.9702
Neck  1.300
(1.115—1.454)
[0.746—1.643]
1.322
(1.107—1.480)
[0.725—1.660]
0.7369
Body 1.222
(1.006;  1.374)
[0.852—1.719]
1.165
(1.005;  1.376)
[0.792—1.607]
0.6950
Tail  1.202
(0.936;  1.323)
[0.805—1.501]
1.150
(0.966;  1.302)
[0.798—1.451]
0.1304
Data are expressed as medians, numbers in parentheses are
ﬁrst quartiles (q1) and third quartiles (q3), numbers in brackets
are ranges. Comparisons were made using the Wilcoxon signed
Table  5  Apparent  diffusion  coefﬁcient  (ADC)
(×  10−3 mm2/s)  values  obtained  at  3.0-Tesla  from
the  four  pancreatic  segments  during  measurements  by
two  independent  readers  (inter-observer  comparison).
Reader  1 Reader  2 P  value
Head 1.286
(1.154;  1.415)
[0.909—1.883]
1.293
(1.224;  1.402)
[0.901—1.827]
0.9702
Neck  1.300
(1.115—1.454)
[0.746—1.643]
1.330
(1.189—1.421)
[0.802—1.598]
0.8813
Body  1.222
(1.006;  1.374)
[0.852—1.719]
1.224
(1.012;  1.300)
[0.806—1.551]
0.9702
Tail  1.202
(0.936;  1.323)
[0.805—1.501]
1.145
(1.006;  1.258)
[0.822—1.411]
0.1506
Data are expressed as medians, numbers in parentheses are
ﬁrst quartiles (q1) and third quartiles (q3), numbers in brackets
are ranges. Comparisons were made using the Wilcoxon signed
9
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0rank test.
Inter-observer variability
The  ADC  values  calculated  for  the  four  pancreatic  segments
by  the  two  readers  at  1.5-T  and  at  3.0-T  are  showed  in
Tables  4  and  5.  No  signiﬁcant  differences  in  ADC  measure-
ments  were  found  for  each  of  the  four  pancreatic  segments
being  considered  at  1.5-  and  3.0-T.
Table  4  Apparent  diffusion  coefﬁcient  (ADC)  values
(×  10−3 mm2/s)  obtained  at  1.5-Tesla  from  the  four
pancreatic  segments  during  measurements  by  two  inde-
pendent  readers  (inter-observer  comparison).
Reader  1  Reader  2  P  value
Head 1.239
(1.155;  1.455)
[0.802—1.819]
1.228
(1.149;  1.425)
[0.808—1.829]
0.2702
Neck  1.311
(1.107-1.480)
[0.725—1.660]
1.256
(1.073—1.477)
[0.728—1.610]
0.0739
Body 1.171
(1.064;  1.315)
[0.757—1.617]
1.170
(1.060;  1.337)
[0.758—1.609]
0.5879
Tail 1.018
(0.946;  1.256)
[0.749—1.663]
1.015
(0.949;  1.259)
[0.779—1.641]
0.6547
Data are expressed as medians, numbers in parentheses are
ﬁrst quartiles (q1) and third quartiles (q3), numbers in brackets
are ranges. Comparisons were made using the Wilcoxon signed
rank test.
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Prank test.
At  1.5-T,  the  mean  absolute  difference  (bias)  and
5%  conﬁdence  intervals  of  the  mean  difference  (lim-
ts  of  agreement)  for  the  head,  neck,  body  and  tail
ere  0.018  ×  10−3 mm2/s  [−0.110  ×  10−3—0.146  ×  10−3],
.018  ×  10−3 mm2/s  [−0.69  ×  10−3—0.106  ×  10−3],
0.005  ×  10−3 mm2/s  [−0.084  ×  10−3—0.074  ×  10−3]  and
.003  ×  10−3 mm2/s  [−0.015  ×  10−3—0.019  ×  10−3],  respec-
ively.  The  95%  limits  of  agreement  between  ADC  values
btained  by  the  two  readers  were  13.8%  of  the  mean  ADC
alue  for  the  head,  14%  for  the  neck,  4.2%  for  the  body  and
.9%  for  the  tail.  Graphic  illustration  of  these  data  with
land-Altman  plots  is  shown  in  Fig.  4.
At  3.0-T,  the  mean  absolute  difference  (bias)  and
5%  conﬁdence  intervals  of  the  mean  difference  (lim-
ts  of  agreement)  for  the  head,  neck,  body  and  tail
ere  —0.001  ×  10−3 mm2/s  [−0.148  ×  10−3—0.146  ×  10−3],
0.001  ×  10−3 mm2/s  [−0.218  ×  10−3—0.215  ×  10−3],
0.003  ×  10−3 mm2/s  [−0.200  ×  10−3—0.195  ×  10−3]  and
.026  ×  10−3 mm2/s  [−0.205  ×  10−3—0.257  ×  10−3],  respec-
ively.  The  95%  limits  of  agreement  between  ADC  values
btained  by  the  two  readers  were  8%  of  the  mean  ADC
alue  for  the  head,  8%  for  the  neck,  25%  for  the  body  and
2.5%  for  the  tail.  Graphic  illustration  of  these  data  with
land-Altman  plots  is  shown  in  Fig.  5.
omparison of apparent diffusion coefﬁcient
alues at 1.5- and 3.0-T
or  each  pancreatic  segment,  ADC  values  obtained  at  1.5-T
ere  similar  to  those  obtained  at  3.0-T  (head:  1.239  ×  10−3
m2/s  vs.  1.286  ×  10−3 mm2/s,  P  =  0.8666;  neck:
−3 2 −3 2.311  × 10 mm /s  vs.  1.300  ×  10 mm /s,  P  =  0.9405;
ody:  1.171  × 10−3 mm2/s  vs.  1.222  ×  10−3 mm2/s,
 =  0.6542;  tail:  1.018  ×  10−3 mm2/s  vs.  1.202  ×  10−3 mm2/s;
 =  0.1169)  (Tables  4  and  5)  (Fig.  6).
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Figure 4. Inter-observer reproducibility of apparent diffusion coefﬁcient (ADC) measurement (× 10−3 mm2/s) at 1.5-T for the four pan-
creatic segments. Bland-Altman plots of difference of ADC measurements (y-axis) against mean ADC measurement (x-axis), with mean
absolute difference (bias) (continuous line) and 95% conﬁdence interval of the mean difference (limits of agreement) (dashed lines).
Figure 5. Inter-observer reproducibility of apparent diffusion coefﬁcient (ADC) measurement (× 10−3 mm2/s) at 3.0-T for the four pan-
creatic segments. Bland-Altman plots of difference of ADC measurements (y-axis) against mean ADC measurement (x-axis), with mean
absolute difference (bias) (continuous line) and 95% conﬁdence interval of the mean difference (limits of agreement) (dashed lines).
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Figure 6. Diagram shows comparison of mean apparent diffu-
sion coefﬁcient (ADC) values (× 10−3 mm2/s) obtained at 1.5-T with
those obtained at 3.0-T for the four pancreatic segments. No sig-
niﬁcant differences were found between the head (P = 0.94), neck
Table  6  P  values  of  paired  comparisons  of  apparent  dif-
fusion  coefﬁcient  (ADC)  values  obtained  from  the  four
pancreatic  segments  at  1.5-  and  3.0-Tesla.
1.5-Tesla 3.0-Tesla
Head  vs.  neck  0.925  0.99
Head  vs.  body 0.430  0.51
Head  vs.  tail 0.039  0.41
Neck  vs.  body 0.430  0.69
Neck  vs.  tail  0.053  0.51
Body  vs.  tail  0.430  0.92
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surement  for  discriminating  between  malignant  and  benign(P = 0.86), body (P = 0.14) and tail (P = 0.49).
At  1.5-T,  a  signiﬁcant  difference  in  ADC  values  was  found
between  the  four  pancreatic  segments  (P  =  0.014)  (Fig.  7).
This  was  due  to  a  lower  median  ADC  value  at  the  pancreatic
tail  by  comparison  with  the  head  (Table  6).  Conversely,  at
3.0-T,  no  signiﬁcant  differences  in  ADC  values  were  found
between  the  different  pancreatic  segments  (P  =  0.16).
p
e
p
Figure 7. Diagram shows comparison of mean apparent diffusion coefﬁ
segments at 1.5- and 3.0-T.Comparisons were made using the Wilcoxon signed rank test.
iscussion
he  results  of  our  study  show  that  ADC  measurements  within
he  four  pancreatic  segments  are  reproducible  on  both  an
ntra-  and  inter-observer  basis.  Our  data  may  serve  as  a
eference  with  respect  to  the  limits  of  error  in  ADC  measure-
ent  for  future  studies  involving  DWI  of  the  pancreas.  It  may
e  reasonably  hypothesized  that  this  will  be  increasingly
one  to  help  detect  and  characterize  pancreatic  abnormal-
ties.
We  have  evaluated  the  reproducibility  of  ADC  mea-
urement  on  both  an  intra-  and  inter-observer  basis.  The
5%  limits  of  agreement  between  ADC  values  obtained  on
epeated  measurements  ranged  from  1%  to  24.2%  for  intra-
bserver  variability  and  from  4.2%  to  25%  for  inter-observer
ariability.  These  results  did  not  substantially  differ  at  1.5-
 and  3.0-T.  However,  we  identiﬁed  the  pancreatic  tail  as
he  segment  that  showed  the  greatest  range  of  variations  in
eproducibility  of  ADC  measurement.
Recent  studies  have  evaluated  the  value  of  ADC  mea-ancreatic  conditions  and  other  have  determined  to  what
xtent  ADC  measurements  help  grade  the  severity  of  chronic
ancreatitis  [10—12]. In  this  regard,  some  authors  found
cient (ADC) values (× 10−3 mm2/s) obtained for the four pancreatic
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hat  pancreatic  tumors  have  ADC  values  signiﬁcantly  lower
han  that  of  normal  pancreatic  parenchyma  [11]. However,
hese  studies  did  not  take  into  account  the  limits  of  margin
rror  for  determining  the  cut-off  values  that  helped  discrim-
nate  between  the  different  conditions  being  compared.  Our
tudy  shows  that  ADC  measurement  of  the  normal  pancreatic
arenchyma  is  subjected  to  variations  so  that  absolute  dif-
erences  in  ADC  values  should  be  interpreted  with  caution.
Previous  studies  have  reported  ADC  values  of  the
ormal  pancreas  using  parallel  imaging  at  1.5-  and
.0-T  and  marked  variations  were  found  among  stud-
es.  Using  a  free-breathing  technique  without  respira-
ory  triggering  and  that  included  b0 for  ADC  calcula-
ion  (0  s/mm2 ≤  b  ≤  800  s/mm2),  Rosenkrantz  et  al.  found
ean  ADC  values  of  1.26  × 10−3 mm2/s  at  1.5-T  and
f  1.39  ×  10−3 mm2/s  at  3.0-T  for  normal  pancreatic
arenchyma,  which  are  close  to  the  ADC  values  we  found
16].  Conversely,  using  a  breath-hold  technique  at  1.5-T  with
wo  b  values  of  50-  and  500-mm2/s,  Wiggermann  et  al.  found
 very  low  mean  ADC  value  of  0.17  × 10−3 mm2/s  [10]. Using
 free-breathing  technique  at  1.5-T  and  three  b  values  of  0-,
00-  and  1000-mm2/s,  another  group  of  researchers  found
DC  values  ranging  from  1.59  × 10−3 mm2/s  to  1.68  ×  10−3
m2/s  for  normal  pancreatic  parenchyma,  with  no  signif-
cant  differences  between  the  three  pancreatic  segments
head,  body  and  tail)  [19]. It  has  been  assumed  that  vari-
tions  in  ADC  values  may  be  the  results  of  differences  in
atient  population,  imaging  sequences,  inclusion  or  not  of
peciﬁc  b  values  for  ADC  calculation,  or  other  technical
arameters  [19,20].  In  accordance  with  Dale  et  al.,  we  did
ot  ﬁnd  any  difference  in  pancreatic  ADC  value  between
DC  values  obtained  at  1.5-T  and  those  obtained  at  3.0-T
21].  In  addition,  our  results  were  within  the  ranges  of  those
eported  by  these  researchers  [21].
Calculation  of  ADC  values  may  be  inﬂuenced  by  the
nclusion  of  low  b  values  as  explained  by  the  intravoxel
ncoherent  motion  (IVIM)  theory  [22,23].  For  a  given  ROI,
e  obtained  a  total  ADC  value  that  consisted  in  the  added
esults  of  diffusion  and  microperfusion  effects.  The  effect  of
icroperfusion  on  the  resulting  total  ADC  is  more  prominent
sing  low  b  values  [24].
In our  study,  we  found  that  the  pancreas  showed  homoge-
eous  distribution  of  ADC  values  among  the  four  segments  at
.0-T.  This  is  consistent  with  the  results  of  Braithwaite  et  al.
15].  Conversely,  we  found  signiﬁcant  differences  between
egments  at  1.5-T,  due  to  a  lower  ADC  value  of  the  tail  by
omparison  with  the  other  three  segments.  A  similar  result
as  found  by  Yoshikawa  et  al.  who  found  lower  ADC  value
or  the  pancreatic  tail  (1.65  ×  10−3 mm2/s  ±  .34)  by  compar-
son  with  the  head  (1.82  × 10−3 mm2/s  ±  .40)  and  the  body
1.81  × 10−3 mm2/s  ±  .41)  [25]. Yoshikawa  et  al.  have  advo-
ated  possible  differences  in  surrounding  tissues  as  a  cause
or  lower  ADC  values  at  the  pancreatic  tail  at  1.5-T  [25].
owever,  there  is  currently  no  plausible  cause  that  may
xplain  the  difference  for  ADC  values  of  the  tail  between
.5-  and  3.0-T.
A few  studies  have  investigated  the  degree  of  repro-
ucibility  of  ADC  measurement  in  the  pancreas.  The  high
egrees  of  reproducibility  may  be  due  in  part  to  the  fact
hat,  except  for  the  tail,  the  pancreas  is  not  affected  by
espiratory  motion.  Conversely,  a  variability  of  20%  in  ADC
xists  when  measurements  are  obtained  from  abdominal
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rgans  that  are  subjected  to  diaphragmatic  movements  dur-
ng  respiration  such  as  the  left  lobe  of  the  liver  [16].
Our  study  has  several  limitations.  One  is  that  the  results
f  ADC  values  we  obtained  may  not  reﬂect  the  variability
f  ADC  values  that  can  be  encountered  in  a  more  gen-
ral  population  because  patients  with  fatty  replacement
f  pancreatic  tissue  or  pancreatic  atrophy  were  excluded
r  because  of  the  speciﬁc  age  category  of  our  population
26—28].  We  agree  that  different  values  might  have  been
btained  with  a  less  restricted  patient  population.  However,
he  goal  of  our  study  was  to  assess  reproducibility  of  ADC
easurement  of  the  normal  pancreas.  A  second  limitation  is
hat  DWI  examinations  at  1.5-T  and  3.0-T  were  obtained  on
wo  different  groups  of  patients  thus  potentially  introducing
 bias  for  further  comparison.  We  agree  that  a  compari-
on  of  ADC  values  obtained  at  1.5-  and  3.0-T  on  the  same
roup  of  patients  would  have  produced  a more  meaningful
tudy.  However,  our  two  groups  of  patients  were  built  with
atients  who  were  strictly  matched  for  age  and  gender  and
atients  with  a  body  mass  index  greater  than  25  kg/m2 were
xcluded.  In  addition,  none  of  them  had  pancreatic  disease,
hus  limiting  this  potential  bias.  A  third  limitation  is  that  we
sed  10  b  factors  for  DWI  but  only  3  b  values  were  obtained
or  ADC  calculation  so  that  we  only  calculated  ADC total.  We
gree  that  further  studies  should  be  done  to  address  this  con-
ern  and  that  the  IVIM  model  should  be  applied  to  evaluate
he  reproducibility  of  perfusion  fraction  (f)  and  that  of  the
erfusion  free  diffusion  parameter  (D)  in  the  normal  pancre-
tic  parenchyma  [29,30]. Similarly,  further  studies  should  be
one  to  investigate  at  what  extent  the  number  of  b  values
ay  affect  the  reproducibility  of  ADC  measurement  [1,5].
onclusion
n  conclusion,  we  found  that  ADC  measurement  of  the  nor-
al  pancreatic  parenchyma  conveys  acceptable  degrees  of
ntra-  and  inter-observer  variability.  However,  the  95%  upper
nd  lower  limits  of  agreement  are  subjected  to  variations
hat  may  act  as  confounders  when  using  ADC  values  as  dis-
riminating  tool.  This  should  be  kept  in  mind  when  ADC
easurement  is  used  for  characterizing  pancreatic  disease
r  grading  the  severity  of  chronic  pancreatitis.
KEY  POINTS
1.  Pancreatic  ADC  measurement  conveys  high  degrees
of  intra-  and  inter-observer  reproducibility.
2.  Pancreatic  segments  have  similar  ADC  values  at  1.5-
and  3.0-Tesla.
3.  The  95%  limits  of  intra-observer  agreement  of
ADC  measurement  are  2.3%—22.7%  at  1.5-Tesla  and
1%—24.2%  at  3.0-Tesla.
4.  The  95%  limits  of  inter-observer  agreement  of
ADC  measurement  are  1.9%—14%  at  1.5-Tesla  and
8%—25%  at  3.0-Tesla.
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